Efekt Revenue and Competitors
Estimated Revenue & Valuation
- Efekt's estimated annual revenue is currently $5.1M per year.
- Efekt's estimated revenue per employee is $189,000
Employee Data
- Efekt has 27 Employees.
- Efekt grew their employee count by -25% last year.
Efekt's People
Name | Title | Email/Phone |
---|
Efekt Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.3M | 59 | 9% | N/A | N/A |
#2 | $179.6M | 532 | 7% | N/A | N/A |
#3 | $6.5M | 30 | 3% | N/A | N/A |
#4 | $5.3M | 28 | -3% | N/A | N/A |
#5 | $12.4M | 51 | 28% | N/A | N/A |
#6 | $13.6M | 56 | -10% | N/A | N/A |
#7 | $6.5M | 30 | -12% | N/A | N/A |
#8 | $18M | 74 | 6% | N/A | N/A |
#9 | $10.2M | 47 | 2% | N/A | N/A |
#10 | $181.6M | 538 | 13% | N/A | N/A |
What Is Efekt?
OUR MISSION To inspire healthy, active, and free-spirited living by providing people and pets access to full-spectrum, THC free, high-value CBD products. VISION Through a passion for living the best life possible, we share our Collective’s journey and adventures in the pursuit of discovery and a happy, healthy and honest life. VALUE A promise found in all our products to always provide the purest, most honest and affordable solutions to promote life balance and positive change. Let us help you "LIVE YOUR BEST LIFE" by providing high-quality CBD products at affordable prices. e’fekt™ CBD products are designed to optimize and balance brain and body function for better focus, performance and recovery. Live healthier and happier, doing whatever it is you and your pets do, by adding the e’fekt™ CBD products that best fit your lifestyle: tincture oils, gel caps, topical balm, chewy treats and our unique CBD rich OPTIMIZe performance drink mix.
keywords:N/AN/A
Total Funding
27
Number of Employees
$5.1M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 27 | 4% | N/A |
#2 | $5.1M | 27 | 0% | N/A |
#3 | $3.4M | 27 | 8% | N/A |
#4 | $2.7M | 27 | -34% | N/A |
#5 | $5.7M | 28 | -12% | N/A |